Drug therapy in children and adolescents with severe bronchial asthma and/or severe atopic dermatitis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028092

Enrollment

100

Registered

2022-03-08

Start date

2022-05-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J45 L20

Interventions

Group 1: Pediatric patients with asthma and/or atopic dermatitis and their caregivers are interviewed once about their experience of the disease, drug use, and possible changes in daily life. This wil

Eligibility

Sex/Gender

All

Age

6 Years to 18 Years

Inclusion criteria

Inclusion criteria: Written consent of parents (or guardians) to participate in the study. Diagnosis of a severe asthma and/or severe atopic dermatitis in paediatric patients Sufficient ability to understand the questions asked Sufficient communication skills

Exclusion criteria

Exclusion criteria: Refusal of participation by the patient or the parents (or guardians) No signature of the consent form No fulfilment of the other inclusion criteria

Design outcomes

Primary

Measure	Time frame
1) Subjective assessment of pediatric patients and their caregivers on illness experience, drug adherence, and daily life changes. 2) Number of drug-related problems with drug administration, assessed via observation of drug demonstrations on a model.	—

Countries

Germany

Contacts

Public ContactMartina Patrizia Neininger

ZAMS - Zentrum für Arzneimittelsicherheit, Universität und Universitätsklinikum Leipzig AöR

klinische.pharmazie@uni-leipzig.de03419711800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026